Recent Press Releases

FDA approves Viekira Pak to treat hepatitis C

The U.S. Food and Drug Administration today approved Viekira Pak (ombitasvir, paritaprevir and ritonavir tablets co-packaged with dasabuvir tablets) to treat patients with chronic hepatitis C virus...

FDA approves Lynparza to treat advanced ovarian cancer

The U.S. Food and Drug Administration today granted accelerated approval to Lynparza (olaparib), a new drug treatment for women with advanced ovarian cancer associated with defective BRCA genes, as...

The Fonds de solidarité FTQ Invests $4 Million in Zymeworks Inc. in Support of Québec's Health Sciences Sector

MONTRÉAL, Canada & VANCOUVER, Canada--The Fonds de solidarité FTQ, a Québec-based development capital fund, today announced an investment of $4 million in common shares of...

ImmunoGen Reports Roche Has Provided an Update on the MARIANNE Trial

WALTHAM, Mass.-- ImmunoGen, Inc. (IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today reported that Roche has...

Acesion Pharma raises 15.2 million DKK in new equity from Novo A/S and Broadview Ventures.

Acesion Pharma, a Danish biotech company developing novel therapeutic treatments for atrial fibrillation (AF), today announced that it has raised 15.2 million DKK (2.5 million USD) in a new equity...

Lundbeck discontinues further development of desmoteplase; 2014 profit guidance range narrowed

Valby, Denmark, 17 December 2014 - H. Lundbeck A/S (Lundbeck) today announced that following the evaluation of the entire available data package including results from DIAS-4 on the investigational...

BerGenBio completes NOK90 million fundraising

Bergen, Norway, December 15, 2014 – BerGenBio AS, a biopharmaceutical company focused on developing innovative drugs for aggressive drug resistant cancers, today announces that it has raised...

Xencor and Novo Nordisk Enter Discovery Collaboration Using Xencor's XmAb Bispecific and Immune Inhibitor Technologies

MONROVIA, Calif., Dec. 18, 2014 /PRNewswire/ -- Xencor, Inc. (XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases,...

Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology

INDIANAPOLIS and LYON, France, Dec. 19, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Adocia (Euronext Paris: FR0011184241 – ADOC) today announced a worldwide licensing...

Lion Biotechnologies, Inc. Names Elma Hawkins President, CEO, And Director

LOS ANGELES, Dec. 15, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc., a biotechnology company that is developing novel cancer immunotherapies based on tumor infiltrating lymphocytes (TIL), today...

Apricus Biosciences (APRI) Appoints Barbara Troupin, M.D. As Chief Medical Officer

SAN DIEGO, Dec. 15, 2014 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced the...

Aurora Algae Appoints Paul Angelico as President and CEO

HAYWARD, Calif.--(BUSINESS WIRE)--Aurora Algae Inc., today announces the appointment of Paul Angelico as President and CEO, effective December 1, 2014. "I am pleased to announce the return of Paul...

Genocea Appoints Eric S. Hoffman as Chief Business Officer

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today announced that Eric S. Hoffman...

Relypsa, Inc. (RLYP) Announces Stephen D. Harrison, M.A., Ph.D., Joins As Senior Vice President And Chief Scientific Officer

REDWOOD CITY, Calif., Dec. 16, 2014 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), today announced that Stephen D. Harrison, M.A., Ph.D., has joined the company as senior vice president and chief...

Applied Proteomics, Inc. Appoints Steve R. Martin As Chief Financial Officer

SAN DIEGO, Dec. 16, 2014 /PRNewswire/ -- Applied Proteomics Inc., the leading developer of protein-based molecular diagnostics, announced today the appointment of Steve R. Martin as chief financial...

SRI International Names Luther Lau Chief Financial Officer

MENLO PARK, Calif., Dec. 15, 2014 /PRNewswire/ -- SRI International has selected Luther Lau as Chief Financial Officer (CFO). Lau has served as SRI's acting CFO since March 2014. In his new...

Trevena, Inc. (TRVN) Appoints Anne M. Phillips To The Board Of Directors

Trevena, Inc. (NASDAQ: TRVN), a clinical stage biopharmaceutical company focused on the discovery and development of G protein coupled receptor (GPCR) biased ligands, today announced that Anne M....

François Garnier Appointed Executive Vice President, General Counsel of Ipsen

Nathalie Joannes Wishes to Give a New Direction to Her Career PARIS--(BUSINESS WIRE)--Regulatory News: "We are very happy to welcome François Garnier to the Ipsen Group. He has spent 25 years...

Biova LLC Names New President, Introduces New COO

JOHNSTON, Iowa, Dec. 16, 2014 (GLOBE NEWSWIRE) -- Biova LLC, the global leader in water soluble egg membrane (WSEM), announces new executive leadership: Matt Stegenga, current director of marketing...

Genentech (RHHBY)'s R&D Chief To Retire; Small Molecule Head Takes Over Top Spot

December 12, 2014 By Mark Terry, BioSpace.com Breaking News Staff Swiss-based Roche announced today that the head of its research operations at Genentech, Richard Schellar, will retire on Dec. 31....